NovoCure20Limited  (NVCR) - NASDAQGS   Revenue / EPS Summary *      Fiscal Quarter 2018 (Fiscal Year) 2017 (Fiscal Year) 2016 (Fiscal Year) March          Revenue $52,125(t) $34,880(t) $13,053(t)    EPS -0.23 (3/31/2018) -0.21 (3/31/2017) -0.42 (3/31/2016)    Dividends N/A N/A N/A June          Revenue $61,514(t) $38,376(t) $17,919(t)    EPS -0.17 (6/30/2018) -0.24 (6/30/2017) -0.48 (6/30/2016)    Dividends N/A N/A N/A September          Revenue $64,756(t) $50,109(t) $21,674(t)    EPS -0.12 (9/30/2018) -0.12 (9/30/2017) -0.39 (9/30/2016)    Dividends N/A N/A N/A December  (FYE)          Revenue $69,674(t) $53,661(t) $30,242(t)    EPS -0.17 (12/31/2018) -0.13 (12/31/2017) -0.25 (12/31/2016)    Dividends N/A N/A N/A Totals          Revenue $248,069(t) $177,026(t) $82,888(t)    EPS -0.69 -0.7 -1.54    Dividends N/A N/A N/A Next 3 Years    Previous 3 Years
©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.